Grufity logoGrufity logo
ScreenerStocksFundsSectorsWatchlists
NXGN

NextGen Healthcare Inc

NXGN

23.94USD Market Closed
Watchlist

Market Summary

USD23.94
Market Closed

NXGN Alerts

  • Big fall in earnings (Y/Y)

NXGN Stock Price

View Fullscreen

NXGN RSI Chart

NXGN Valuation

Market Cap

1.6B

Price/Earnings (Trailing)

-258.5

Price/Sales (Trailing)

2.31

EV/EBITDA

96.95

Price/Free Cashflow

-171.69

NXGN Price/Sales (Trailing)

NXGN Profitability

EBT Margin

0.66%

Return on Equity

-0.66%

Return on Assets

-0.3%

Free Cashflow Yield

-0.58%

NXGN Fundamentals

NXGN Revenue

Revenue (TTM)

695.1M

Revenue Y/Y

10.65%

Revenue Q/Q

-1%

NXGN Earnings

Earnings (TTM)

-6.2M

Earnings Y/Y

-62.89%

Earnings Q/Q

-17.88%

Price Action

Last 7 days

0.0%

Last 30 days

0.5%

Last 90 days

41.7%

Trailing 12 Months

18.9%

How does NXGN drawdown profile look like?

NXGN Financial Health

Current Ratio

2.03

NXGN Investor Care

Buy Backs (1Y)

1.05%

Diluted EPS (TTM)

-0.1

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2023653.2M678.1M695.1M0
2022596.4M603.6M613.7M625.9M
2021556.8M572.0M581.3M589.3M
2020540.2M539.3M545.0M549.0M
2019529.2M527.8M531.8M538.6M
2018531.0M533.3M531.0M530.2M
2017509.6M518.3M523.8M527.6M
2016492.5M492.5M494.3M505.2M
2015490.2M494.5M499.3M493.0M
2014444.7M453.0M462.5M477.0M
2013444.7M444.7M444.7M444.7M
2012460.2M451.5M446.4M440.8M
2011353.4M388.7M423.4M446.0M
2010291.8M308.1M317.9M334.8M
2009245.5M257.1M268.7M280.2M

Latest Insider Trading transactions for NXGN

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Nov 09, 2023
klapstein julie d
back to issuer
-
-
-70,104
-
Nov 09, 2023
waters mitchell
back to issuer
-
-
-57,931
evp, commercial growth
Nov 09, 2023
panner morris
back to issuer
-
-
-100,043
-
Nov 09, 2023
velamoor srinivas s
back to issuer
-
-
-361,586
see remarks
Nov 09, 2023
mcginty geraldine
back to issuer
-
-
-32,877
-
Nov 09, 2023
sides david william
back to issuer
-
-
-605,540
president and ceo
Nov 09, 2023
margolis jeffrey h
back to issuer
-
-
-136,393
-
Nov 09, 2023
puryear pamela
back to issuer
-
-
-31,028
-
Nov 09, 2023
bristol george h
back to issuer
-
-
-82,889
-
Nov 09, 2023
ahmadzai david
back to issuer
-
-
-44,555
chief accounting officer

1–10 of 50

Which funds bought or sold NXGN recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Dec 06, 2023
CITIGROUP INC
reduced
-55.14
-259,012
494,747
-%
Nov 29, 2023
Carmignac Gestion
new
-
1,183,680
1,183,680
0.02%
Nov 24, 2023
DEUTSCHE BANK AG\
added
15.68
286,645
700,628
-%
Nov 22, 2023
Public Sector Pension Investment Board
reduced
-29.32
52,497
1,592,160
0.01%
Nov 22, 2023
KBC Group NV
unchanged
-
-
76,000
-%
Nov 21, 2023
Walleye Capital LLC
sold off
-100
-177,852
-
-%
Nov 21, 2023
COMERICA BANK
new
-
595,528
595,528
-%
Nov 17, 2023
JACOBS LEVY EQUITY MANAGEMENT, INC
sold off
-100
-554,351
-
-%
Nov 17, 2023
Diversified Trust Co
sold off
-100
-199,489
-
-%
Nov 16, 2023
Financial Gravity Asset Management, Inc.
sold off
-100
-497
-
-%

1–10 of 45

Latest Funds Activity

Are funds buying NXGN calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own NXGN
No. of Funds

Schedule 13G FIlings of NextGen Healthcare Inc

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Oct 10, 2023
vanguard group inc
10.40%
6,976,720
SC 13G/A
Jun 16, 2023
three prong investments, llc
14.99%
9,889,827
SC 13G
Feb 09, 2023
vanguard group inc
9.45%
6,389,869
SC 13G/A
Jan 27, 2023
blackrock inc.
14.3%
9,663,011
SC 13G/A
Jan 23, 2023
blackrock inc.
14.4%
9,760,374
SC 13G/A
Feb 10, 2022
vanguard group inc
9.50%
6,495,700
SC 13G/A
Jan 27, 2022
blackrock inc.
14.5%
9,930,776
SC 13G/A
Jan 25, 2022
blackrock inc.
14.5%
9,930,776
SC 13G/A
Jan 10, 2022
brown capital management llc
2.19%
1,495,268
SC 13G/A
Nov 10, 2021
brown capital management llc
7.50%
5,129,916
SC 13G/A

Recent SEC filings of NextGen Healthcare Inc

View All Filings
Date Filed Form Type Document
Nov 20, 2023
15-12G
15-12G
Nov 13, 2023
4
Insider Trading
Nov 13, 2023
4
Insider Trading
Nov 13, 2023
4
Insider Trading
Nov 13, 2023
4
Insider Trading
Nov 13, 2023
4
Insider Trading
Nov 13, 2023
4
Insider Trading
Nov 13, 2023
4
Insider Trading
Nov 13, 2023
4
Insider Trading
Nov 13, 2023
4
Insider Trading

Peers (Alternatives to NextGen Healthcare Inc)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
508.3B
360.0B
3.01% 2.26%
23.44
1.41
14.24% 11.62%
94.6B
347.8B
3.40% -27.36%
10.86
0.27
10.34% 159.11%
91.1B
189.9B
-16.07% -21.54%
13.64
1.92
5.24% 22.27%
67.9B
63.2B
9.26% 6.66%
11.88
1.07
5.62% 6.32%
39.8B
150.1B
3.58% -13.41%
16.28
0.27
6.04% 21.35%
MID-CAP
9.5B
11.9B
31.87% 41.05%
15.62
0.8
2.36% -10.41%
9.5B
14.0B
4.29% 5.69%
14.01
0.68
6.03% -8.61%
8.7B
2.2B
-0.89% 11.07%
35.56
3.91
4.50% -6.69%
6.5B
2.9B
-3.21% -16.01%
-355.14
2.27
13.16% -106.47%
2.6B
4.1B
4.80% -41.77%
9.22
0.63
-25.26% -41.25%
SMALL-CAP
1.6B
1.3B
14.14% 13.10%
34.97
1.18
27.06% -27.04%
1.5B
1.0B
6.20% -15.59%
25.32
1.42
10.84% 30.19%
975.1M
3.0B
25.73% 68.73%
-7.9
0.33
6.98% 58.07%
38.7M
-
11.36% -69.57%
-2.67
-
- -27.68%
15.3M
20.7M
3.46% -16.14%
52.66
0.74
6.53% -78.75%

NextGen Healthcare Inc News

Latest updates
Defense World24 Nov 202307:39 am13 days ago
MENAFN.COM29 Oct 202302:31 am39 days ago
Yahoo Finance24 Oct 202307:00 am44 days ago
Business Wire24 Oct 202307:00 am44 days ago
Yahoo Finance24 Oct 202307:00 am44 days ago
InvestorPlace19 Oct 202307:00 am49 days ago
PR Newswire18 Oct 202307:00 am50 days ago
Nasdaq11 Oct 202307:00 am57 days ago
GlobeNewswire08 Oct 202307:00 am2 months ago
The Motley Fool08 Sep 202307:00 am3 months ago
Investopedia06 Sep 202307:00 am3 months ago
Investopedia06 Sep 202307:00 am3 months ago
CoinChapter06 Sep 202307:00 am3 months ago
Yahoo Finance04 Sep 202307:00 am3 months ago

Financials for NextGen Healthcare Inc

Income Statement (Last 12 Months)
(In Thousands)
Income Statement (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q3
Revenue-1.0%176,418178,207178,550161,877159,443153,302151,259149,721149,286146,084144,188141,752140,002130,879136,382137,740134,256131,861134,785130,867130,321
Gross Profit2.3%81,62179,82184,52076,52876,86373,24875,49875,51776,58873,34374,40771,42871,05264,51068,04369,60568,52266,63072,72869,19669,203
Operating Expenses4.0%73,56570,755108,42966,96467,57472,05872,68567,50984,48569,60974,69770,49660,75462,63374,33266,32561,79165,24066,19163,01353,721
  S&GA Expenses12.4%54,17548,19383,32746,17744,88649,03450,04647,23863,89148,48648,87048,97241,95040,73743,15942,84139,04640,12844,71041,30434,229
  R&D Expenses-13.9%18,02020,92520,02719,62120,85721,79519,42819,39018,51819,32121,39018,19717,69218,22221,42920,02619,78922,05119,81320,68218,371
EBITDA Margin---0.02*0.06*0.06*0.02*0.02*0.02*0.01*0.04*0.02*0.01*0.02*0.01*0.01*0.03*-----
Interest Expenses2.2%3,3103,2393,4042,2393253305413213203176436311,1351,107661435387472595720769
Income Taxes-31.3%1,6412,3904791,0195,707-2471,9252,535-1,441559-389-169-1,2981,616-1,965-1,403509-3802,0004561,896
Earnings Before Taxes-21.6%6,6968,546-24,7618,83419,3309012,2737,728-8,2123,407-9692959,157792-6,2073,0126,5908645,9285,28014,990
EBT Margin---0.01*0.05*0.05*0.00*0.01*0.00*-0.01*0.02*0.02*0.01*0.01*0.01*0.01*0.03*-----
Net Income-17.9%5,0556,156-25,2407,81513,6231,1483485,193-6,7712,848-58046410,455-824-4,2424,4156,0811,2443,9284,82413,094
Net Income Margin---0.00*0.04*0.03*0.00*0.00*0.00*-0.01*0.02*0.02*0.01*0.02*0.01*0.01*0.03*-----
Free Cashflow---7,4641,54937,470-5,10016,36415,80519,483-68920,32527,16430,21217,05620,73221,849-----
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q3
Assets-1.2%858868896871627608628605636625644656672770720623573567533531536
  Current Assets-3.2%363375402390218193212186211194208217225317260153170156160158159
    Cash Equivalents-23.4%54.0070.0099.0024278.0048.0067.0054.0082.0070.0079.0094.0010920014032.0050.0037.0035.0037.0040.00
  Inventory----------------0.000.000.000.000.000.00
  Net PPE-11.2%5.006.006.007.007.008.009.0011.0012.0013.0015.0015.0017.0019.0020.0022.0022.0023.0021.0023.0025.00
  Goodwill0.1%32232232232126726726726726726726726726726726719.005.00219219219219
Liabilities-5.1%434458496453185179205194200186213230253366320223182186157165180
  Current Liabilities-14.3%144168198154169158181170171155181160137138143137132128128120119
Shareholder's Equity3.1%423411400418442429423411435439432426420404400400391381376365355
  Retained Earnings3.8%139134128153145131130130125131129129129118119123119113112108103
  Additional Paid-In Capital1.9%371364359352344337330318312308304298292287283277273268265258254
Accumulated Depreciation-4.3%58.0060.0061.0063.0068.0068.0069.0070.0068.0067.0065.0063.0063.0061.0059.0057.0055.0053.0051.0049.0048.00
Shares Outstanding0.1%67.0067.0066.0066.0068.0068.0067.0068.0067.0067.0067.0067.0067.0066.0066.0065.0065.0065.0065.0065.0064.00
Cashflow (Last 12 Months)
(In Millions)
Cashflow (Quarterly)
Description(%) Q/Q2023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q3
Cashflow From Operations-16.3%-9,418,000-8,097,0007,683,0002,181,00038,441,000-4,645,00016,909,00016,157,00020,166,000313,00022,540,00027,946,00030,360,00017,672,00021,230,00023,607,00023,767,00016,997,00017,196,00018,363,00011,904,000
  Share Based Compensation19.0%9,466,0007,956,0006,942,0009,063,0008,687,0008,766,0007,867,0007,050,0005,223,0006,412,0005,947,0005,933,0005,437,0005,393,0005,866,0004,621,0004,316,0004,891,0004,153,0004,698,0004,135,000
Cashflow From Investing56.8%-7,202,000-16,686,000-151,732,000-56,573,000864,000-9,453,000-8,208,000-6,476,000-6,858,000-6,540,000-7,879,000-7,613,000-6,825,000-6,228,000-5,231,000-78,247,000-4,170,000-8,424,000-6,562,000-5,641,000-6,356,000
Cashflow From Financing25.3%-2,426,000-3,248,000566,000225,484,000-9,322,000-4,105,0003,696,000-36,895,000-1,794,000-2,298,000-29,817,000-35,447,000-115,045,00048,592,00091,834,00036,695,000-5,956,000-6,305,000-13,555,000-14,997,000106,000
  Buy Backs----40,000,0007,373,0002,505,000---------------

NXGN Income Statement

2023-09-30
Condensed Consolidated Statements of Net Income and Comprehensive Income (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended6 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Revenues:    
Total revenues$ 176,418$ 159,443$ 354,625$ 312,745
Cost of revenue:    
Amortization of capitalized software costs and acquired intangible assets7,1816,74414,17213,878
Total cost of revenue94,79782,580193,183162,634
Gross profit81,62176,863161,442150,111
Operating expenses:    
Selling, general and administrative54,17544,886102,36893,920
Research and development costs, net18,02020,85738,94542,652
Amortization of acquired intangible assets1,1897052,3771,410
Impairment of assets1668055251,329
Restructuring costs15321105321
Total operating expenses73,56567,574144,320139,632
Income from operations8,0569,28917,12210,479
Interest income1,520743,189120
Interest expense(3,310)(325)(6,549)(655)
Other income, net43010,2921,48010,287
Income before provision for income taxes6,69619,33015,24220,231
Provision for income taxes1,6415,7074,0315,460
Net income5,05513,62311,21114,771
Other comprehensive income:    
Foreign currency translation, net of tax(76)(5)(77)(33)
Unrealized gain (loss) on marketable securities, net of tax734 (42) 
Comprehensive income$ 5,713$ 13,618$ 11,092$ 14,738
Net income per share:    
Basic$ 0.08$ 0.2$ 0.17$ 0.22
Diluted$ 0.07$ 0.2$ 0.17$ 0.22
Weighted-average shares outstanding:    
Basic67,07467,80666,74967,698
Diluted67,69068,42267,28068,353
Recurring    
Revenues:    
Total revenues$ 161,316$ 143,503$ 324,690$ 283,262
Cost of revenue:    
Cost of revenue excluding amortization of capitalized software costs and acquired intangible assets75,58565,039154,806127,283
Software, hardware, and other non-recurring    
Revenues:    
Total revenues15,10215,94029,93529,483
Cost of revenue:    
Cost of revenue excluding amortization of capitalized software costs and acquired intangible assets$ 12,031$ 10,797$ 24,205$ 21,473

NXGN Balance Sheet

2023-09-30
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Sep. 30, 2023
Mar. 31, 2023
Current assets:  
Cash and cash equivalents$ 53,867$ 98,719
Restricted cash and cash equivalents4,9147,269
Marketable securities146,432139,612
Accounts receivable, net89,27788,498
Contract assets20,48919,561
Income taxes receivable8,1345,248
Prepaid expenses and other current assets39,68442,916
Total current assets362,797401,823
Equipment and improvements, net4,9396,421
Capitalized software costs, net59,87554,516
Operating lease assets2,6153,335
Deferred income taxes, net29,21029,472
Contract assets, net of current5,6165,572
Intangibles, net24,48028,968
Goodwill322,001321,756
Other assets46,21744,238
Total assets857,750896,101
Current liabilities:  
Accounts payable10,46712,022
Contract liabilities45,93261,601
Accrued compensation and related benefits28,40736,241
Income taxes payable604622
Operating lease liabilities3,4713,826
Other current liabilities54,99783,799
Total current liabilities143,878198,111
Contract liabilities, net of current2,80910,310
Deferred compensation8,7228,033
Convertible senior notes, net, noncurrent267,565266,843
Operating lease liabilities, net of current2,4644,095
Other noncurrent liabilities9,0378,274
Total liabilities434,475495,666
Commitments and contingencies (Note 17)
Shareholders' equity:  
Common stock, $0.01 par value; authorized 100,000 shares; 71,946 shares and 70,875 shares issued at September 30, 2023 and March 31, 2023, respectively; 67,097 shares and 66,026 shares outstanding at September 30, 2023 and March 31, 2023, respectively719709
Treasury stock, at cost, 4,849 shares and 4,849 shares at September 30, 2023 and March 31, 2023, respectively(85,752)(85,752)
Additional paid-in capital371,080359,342
Accumulated other comprehensive loss(1,581)(1,462)
Retained earnings138,809127,598
Total shareholders' equity423,275400,435
Total liabilities and shareholders' equity$ 857,750$ 896,101
NXGN
NextGen Healthcare, Inc. provides healthcare technology solutions in the United States. The company offers clinical care solutions, including NextGen Enterprise EHR; financial solutions, such as NextGen Enterprise PM; patient engagement solutions comprising NextGen Virtual Visits; integrated clinical care and financial solutions consisting of NextGen Office; interoperability solutions that include NextGen Share and Mirth Connect; data and analytics solutions, which comprise NextGen Health Data Hub; and value based care solutions, including NextGen Population Health Solutions. It also provides managed services, such as revenue cycle management services comprising billing and collections, electronic claims submission and denials management, electronic remittance and payment posting, and accounts receivable follow-up; and client and support services. Further, the company offers professional services consisting of training, project management, installation services, and application managed services; and consulting services that include physician, professional, and technical consulting; assisting clients to optimize their staffing and software solutions; enhancing financial and clinical outcomes; achieving regulatory requirements; and meeting the requirements of healthcare reform. It serves accountable care organizations, independent physician associations, managed service organizations, veterans service organizations, dental service organizations, ambulatory care centers, and community health centers through a direct sales force and reseller channel. The company was formerly known as Quality Systems, Inc. and changed its name to NextGen Healthcare, Inc. in September 2018. NextGen Healthcare, Inc. was incorporated in 1974 and is based in Atlanta, Georgia.
 CEO
 WEBSITEwww.nextgen.com
 EMPLOYEES2783

NextGen Healthcare Inc Frequently Asked Questions


What is the ticker symbol for NextGen Healthcare Inc? What does NXGN stand for in stocks?

NXGN is the stock ticker symbol of NextGen Healthcare Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of NextGen Healthcare Inc (NXGN)?

As of Tue Nov 14 2023, market cap of NextGen Healthcare Inc is 1.61 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of NXGN stock?

You can check NXGN's fair value in chart. The fair value of NextGen Healthcare Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of NextGen Healthcare Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for NXGN so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is NextGen Healthcare Inc a good stock to buy?

The fair value guage provides a quick view whether NXGN is over valued or under valued. Whether NextGen Healthcare Inc is cheap or expensive depends on the assumptions which impact NextGen Healthcare Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for NXGN.

What is NextGen Healthcare Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Tue Nov 14 2023, NXGN's PE ratio (Price to Earnings) is -258.5 and Price to Sales (PS) ratio is 2.31. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. NXGN PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on NextGen Healthcare Inc's stock?

In the past 10 years, NextGen Healthcare Inc has provided 0.013 (multiply by 100 for percentage) rate of return.